For patients with early-stage triple-negative breast cancer (TNBC), finishing chemotherapy and surgery should feel like the end of the hardest chapter. But for many, it marks the beginning of a ...

Ultrasensitive circulating tumor DNA (ctDNA) testing may help identify women with triple-negative breast cancer who are at either a very high or very low risk for recurrence after surgery, new ...

The FDA has approved Datroway (datopotamab deruxtecan) for adults with unresectable or metastatic triple‑negative breast ...

Hearing the words “triple-negative breast cancer” (TNBC) can be overwhelming. It’s a diagnosis that sounds heavy — not just because breast cancer itself is frightening, but because this particular ...

While radiation therapy is an effective tool to destroy cancer cells, a new study from Vanderbilt researchers suggests that in an aggressive form of breast cancer, it may also trigger a protective ...

A pioneering personalized mRNA vaccine study reveals lasting immune responses in triple-negative breast cancer, offering early signals that tailored cancer vaccination may help improve long-term ...

A global, multicenter phase III trial, TROPION-Breast02, led by a senior medical oncologist and researcher from the National Cancer Centre Singapore, has demonstrated a significant breakthrough in ...

While triple-negative breast cancer (TNBC) is generally an aggressive subtype, it is highly heterogeneous, with a subset of patients having a more favorable biology and high responsiveness to systemic ...

A new study has revealed a promising new approach to curb the spread of triple‑negative breast cancer, one of the most aggressive and difficult‑to‑treat forms of the disease. Published recently in ...

Scientists at HSE University have identified a molecular mechanism underlying aggressive breast cancer. They found that the signals supporting tumour growth originate not from the tumour itself but ...